As the most common and fatal types of hematopoietic malignancies, acute myeloid leukemia (AML) is recently reported to aberrantly upregulate FTO expression, especially in AML cases with t(11q23)/MLL‐rearranged chromosomal abnormalities. Here, KMT2A is linked to acute myeloid leukemia.